Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study

Conclusion:
This suggests that serum advanced glycation endproducts are associated with impaired left ventricular function in normal glucose metabolism, but that with deteriorating glucose metabolism status, serum advanced glycation endproducts may not mirror heart failure risk.

Source: Diabetes and Vascular Disease Research - May 22, 2016 Category: Endocrinology Authors: Linssen, P. B., Henry, R. M., Schalkwijk, C. G., Dekker, J. M., Nijpels, G., Brunner-La Rocca, H.-P., Stehouwer, C. D. Tags: Original Articles Source Type: research